Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

Patent Law

: IPBiz

Controversy surrounds research on "human sperm" from stem cells

By Lawrence B. Ebert, Esq.

AP noted the publication by the research group of Karim Nayernia, of Newcastle University in the journal Stem Cells and Development on the topic of creating human sperm from embryonic stem cells but separately noted the work had been criticized by Allan Pacey, a senior lecturer in andrology at the University of Sheffield and Azim Surani, a professor of physiology and reproduction at the University of Cambridge.

Of Nayernia, note previous IPBiz posts:

http://ipbiz.blogspot.com/2006/06/nayernia-to-join-stem-cell-effort-at.html

http://ipbiz.blogspot.com/2006/07/nayernia-of-newcastle-makes-mouse.html

***One notes that Nayernia's development transpired outside the US, and outside the scope of California's CIRM, but during the time period CIRM existed. While things are happening in stem cell technology, the blog californiastemcellreport gave information on lobbying efforts, which included the memorable line:

?in the age of Obama, it?s a particularly good time to be named Podesta.?

referencing the successful lobbying efforts of Tony Podesta (brother of John Podesta of the Obama team) on behalf of an pharma industry-backed bill to stall competition from generic companies. Yes, you got that right, a pro-pharma bill.

Full post as published by IPBiz on July 24, 2009 (boomark / email).